
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[CVAC] CureVac N.V. - Operating Cash Flow / Sales
Data updated 2023-Jun-24 (Saturday)Note: Detailed Statistics for Operating Cash Flow / Sales in Cashflow Statement for CureVac N.V. [NASDAQ:CVAC] with frequency distribution chart that analyze trends & history . Operating Cash Flow / Sales or Revenue metric is expressed as a % for period. View Cashflow Statement for broader context
Share
Quarterly Operating Cash Flow / Sales values for CureVac N.V. are rounded to enhance readability
2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | 2021-Dec | |
---|---|---|---|---|---|---|
Operating Cash Flow / Sales | -1,307.3% | -446.4% | -217.8% | -284.3% | -560.1% | -402.4% |
Sequential Quarter Growth | -192.8% | -105.0% | +23.4% | +49.2% | -39.2% | +49.4% |
Quarter-on Quarter Growth | -133.4% | -11.0% | +72.6% | +2.1% | +65.7% | -106.6% |
Annual Operating Cash Flow / Sales values for CureVac N.V. are rounded to enhance readability
2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | |
---|---|---|---|---|---|
Operating Cash Flow / Sales | -424.5% | -711.8% | 1,068.9% | -499.3% | -575.8% |
Year-on-Year Growth | +40.4% | -166.6% | +314.1% | +13.3% | |
2-yr CAGR | |||||
3-yr CAGR | |||||
4-yr CAGR | |||||
5-yr CAGR |
Frequency distribution of quarterly Operating Cash Flow / Sales values from 2019-Mar-31 grouped into buckets. Latest Operating Cash Flow / Sales value is -1.31 Thousand as of 2023-Mar-31
Subsequent stock performance post earnings date till next announcement for CureVac N.V. mapped with quarterly Operating Cash Flow / Sales values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Operating Cash Flow / Sales above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for CureVac N.V. with subsequent post-earnings performance given Operating Cash Flow / Sales values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (relative perf.) | Outperform (relative perf.) | |
---|---|---|
Operating Cash Flow / Sales - Low | 100% | 0% |
Operating Cash Flow / Sales - Medium | 100% | 0% |
Operating Cash Flow / Sales - High | 0% | 100% |
Operating Cash Flow / Sales (Sequential growth %) - Low | 57% | 43% |
Operating Cash Flow / Sales (Sequential growth %) - Medium | 57% | 43% |
Operating Cash Flow / Sales (Sequential growth %) - High | 100% | 0% |
Operating Cash Flow / Sales (QoQ growth %) - Low | 57% | 43% |
Operating Cash Flow / Sales (QoQ growth %) - Medium | 100% | 0% |
Operating Cash Flow / Sales (QoQ growth %) - High | 100% | 0% |
Related to CureVac N.V.
Information for CureVac N.V.
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-22 on Google
SEC Reports : Quarterly reports around 2025-May-22 on SEC Edgar
Compare CureVac N.V. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes CureVac N.V.
Industry : Biotechnology industry performance which includes CureVac N.V.